Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Promedicamento")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 5950

  • Page / 238
Export

Selection :

  • and

Evaluating Aziridinyl Nitrobenzamide Compounds as Leishmanicidal ProdrugsVOAK, Andrew A; SEIFERT, Karin; HELSBY, Nuala A et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 1, pp 370-377, issn 0066-4804, 8 p.Article

Strategies in the design of solution-stable, water-soluble prodrugs. I: A physical-organic approach to pro-moiety selection for 21-esters of corticosteroidsANDERSON CONRADI, R. A; KNUTH, K. E.Journal of pharmaceutical sciences. 1985, Vol 74, Num 4, pp 365-374, issn 0022-3549Article

Strategies in the design of solution-stable, water-soluble prodrugs. II: Properties of micellar prodrugs of methyl-prednisoloneANDERSON, B. D; CONRADI, R. A; KNUTH, K. E et al.Journal of pharmaceutical sciences. 1985, Vol 74, Num 4, pp 375-381, issn 0022-3549Article

Strategies in the design of solution-stable, water-soluble prodrugs. III: Influence of the pro-moiety on the bioconversion of 21-esters of corticosteroidsANDERSON, B. D; CONRADI, R. A; SPILMAN, C. H et al.Journal of pharmaceutical sciences. 1985, Vol 74, Num 4, pp 382-387, issn 0022-3549Article

Metabolism of 3-(chlorophenyl)pyrrolidine. Structural effects in conversion of a prototype γ-aminobutyric acid prodrug to lactam and γ-aminobutyric acid type metabolitesWALL, G. M; BAKER, J. K.Journal of medicinal chemistry (Print). 1989, Vol 32, Num 6, pp 1340-1348, issn 0022-2623, 9 p.Article

Trypanocidal Activity of Aziridinyl Nitrobenzamide ProdrugsBOT, Chris; HALL, Belinda S; BASHIR, Noosheen et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 10, pp 4246-4252, issn 0066-4804, 7 p.Article

Prodrug Strategy to Achieve Lyophilizable, High Drug Loading Micelle Formulations Through Diester Derivatives of β-LapachoneXINPENG MA; XIUMEI HUANG; GANG HUANG et al.Advanced healthcare materials (Print). 2014, Vol 3, Num 8, pp 1210-1216, issn 2192-2640, 7 p.Article

Multimodal image-guided enzyme/prodrug cancer therapyCONG LI; WINNARD, Paul T; TAKAGI, Tomoyo et al.Journal of the American Chemical Society. 2006, Vol 128, Num 47, pp 15072-15073, issn 0002-7863, 2 p.Article

Comparative preclinical pharmacokinetic and metabolic studies of the Combretastatin prodrugs Combretastatin A4 phosphate and A1 phosphateKIRWAN, Ian G; LOADMAN, Paul M; SWAINE, David J et al.Clinical cancer research. 2004, Vol 10, Num 4, pp 1446-1453, issn 1078-0432, 8 p.Article

An analytical method to determine small quantities of phenytoin in the presence of excess amounts of one of its prodings, the monomethane sulphonate salt of 3-(N,N-dimethylglycyloxymethyl)-5,5-diphenyl-hydantoinMULLER, D. G; STELLA, V. J.Journal of pharmaceutical and biomedical analysis. 1987, Vol 5, Num 4, pp 415-421, issn 0731-7085Article

The 2-Nitroimidazole EF5 Is a Biomarkerfor Oxidoreductases That Activate the Bioreductive Prodrug CEN-209 under HypoxiaJINGLI WANG; FOEHRENBACHER, Annika; JIECHUANG SU et al.Clinical cancer research (Print). 2012, Vol 18, Num 6, pp 1684-1695, issn 1078-0432, 12 p.Article

The Bioreductive Prodrug PR-104A Is Activated under Aerobic Conditions by Human Aldo-Keto Reductase 1C3GUISE, Christopher P; ABBATTISTA, Maria R; DONATE, Fernando et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 4, pp 1573-1584, issn 0008-5472, 12 p.Article

Pharmacological properties of a new antimalarial bisthiazolium salt, T3, and a corresponding prodrug, TE3NICOLAS, Olivier; MARGOUT, Delphine; TAUDON, Nicolas et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 9, pp 3631-3639, issn 0066-4804, 9 p.Article

Prodrugs revisited : The ad hoc appraoch as a complement to ligand designTESTA, B; CALDWELL, J.Medicinal research reviews (Print). 1996, Vol 16, Num 3, pp 233-241, issn 0198-6325Article

Future of prodrugs in antiviral therapyHASEGAWA, T; KAWAGUCHI, T.Clinical pharmacokinetics. 1994, Vol 27, Num 5, pp 331-336, issn 0312-5963Article

A Screen for and Validation of Prodrug AntimicrobialsFLECK, Laura E; JEFFREY NORTH, E; LEE, Richard E et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 3, pp 1410-1419, issn 0066-4804, 10 p.Article

Modular theranostic prodrug based on a FRET-activated self-immolative linerREDY, Orit; SHABAT, Doron.Journal of controlled release. 2012, Vol 164, Num 3, pp 276-282, issn 0168-3659, 7 p.Article

Stereochemical implications of hybrid and pseudo-hybrid drugs. IIIARIENS, E. J.Medicinal research reviews (Print). 1988, Vol 8, Num 2, pp 309-320, issn 0198-6325Article

DTS-108, A Novel Peptidic Prodrug of SN38 : In vivo Efficacy and Toxicokinetic StudiesMEYER-LOSIC, Florence; NICOLAZZI, Céline; ARRANZ, Valérie et al.Clinical cancer research. 2008, Vol 14, Num 7, pp 2145-2153, issn 1078-0432, 9 p.Article

Cefuroxime axetilEMMERSON, A. M.Journal of antimicrobial chemotherapy (Print). 1988, Vol 22, Num 2, pp 101-104, issn 0305-7453Article

Prodrugs of cyanamide as (long-acting) alcohol deterrent agentsNAGASAWA, H. T; CHUL-HOON KWON; DE MASTER, E. G et al.Biochemical pharmacology. 1986, Vol 35, Num 2, pp 129-132, issn 0006-2952Article

Phase behaviour of a diglyceride prodrug: spontaneous formation of unilamellar vesiclesMANTELLI, S; SPEISER, P; HAUSER, H et al.Chemistry and physics of lipids. 1985, Vol 37, Num 4, pp 329-343, issn 0009-3084Article

The pharmacology of prodrugs of 5-fluorouracil and 1-β-D-arabinofuranosylcytosineHADFIELD, A. F; SARTORELLI, A. C.Advances in pharmacology and chemotherapy. 1984, Vol 20, pp 21-67, issn 0065-3144Article

Prodrugs: Pharmaceutical Design and Current PerspectivesJAMPILEK, Josef.Current pharmaceutical design (Print). 2011, Vol 17, Num 32, issn 1381-6128, 129 p.Serial Issue

Predictive Physiologically Based Pharmacokinetic Model for Antibody-Directed Enzyme Prodrug TherapyLANYAN FANG; DUXIN SUN.Drug metabolism and disposition. 2008, Vol 36, Num 6, pp 1153-1165, issn 0090-9556, 13 p.Article

  • Page / 238